408 related articles for article (PubMed ID: 34489588)
1. Synthetic biomarkers: a twenty-first century path to early cancer detection.
Kwong GA; Ghosh S; Gamboa L; Patriotis C; Srivastava S; Bhatia SN
Nat Rev Cancer; 2021 Oct; 21(10):655-668. PubMed ID: 34489588
[TBL] [Abstract][Full Text] [Related]
2. The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review.
Cree IA; Uttley L; Buckley Woods H; Kikuchi H; Reiman A; Harnan S; Whiteman BL; Philips ST; Messenger M; Cox A; Teare D; Sheils O; Shaw J;
BMC Cancer; 2017 Oct; 17(1):697. PubMed ID: 29061138
[TBL] [Abstract][Full Text] [Related]
3. Update on urine as a biomarker in cancer: a necessary review of an old story.
Zhang W; Zhang XJ; Chao SY; Chen SJ; Zhang ZJ; Zhao J; Lv YN; Yao JJ; Bai YY
Expert Rev Mol Diagn; 2020 May; 20(5):477-488. PubMed ID: 32212972
[No Abstract] [Full Text] [Related]
4. Mathematical model identifies blood biomarker-based early cancer detection strategies and limitations.
Hori SS; Gambhir SS
Sci Transl Med; 2011 Nov; 3(109):109ra116. PubMed ID: 22089452
[TBL] [Abstract][Full Text] [Related]
5. Analysis of DNA Methylation Status in Bodily Fluids for Early Detection of Cancer.
Yokoi K; Yamashita K; Watanabe M
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28358330
[TBL] [Abstract][Full Text] [Related]
6. Cancer metabolomic markers in urine: evidence, techniques and recommendations.
Dinges SS; Hohm A; Vandergrift LA; Nowak J; Habbel P; Kaltashov IA; Cheng LL
Nat Rev Urol; 2019 Jun; 16(6):339-362. PubMed ID: 31092915
[TBL] [Abstract][Full Text] [Related]
7. [Bladder cancer screening with urine-based tumour markers - occupational medical experience].
Nasterlack M; Feil G; Leng G; Pesch B; Huber S; Sievert KD; Johnen G; Taeger D; Mayer T; Kluckert M; Brüning T; Stenzl A
Aktuelle Urol; 2011 Mar; 42(2):128-34. PubMed ID: 21437837
[TBL] [Abstract][Full Text] [Related]
8. -The advancement of biomarker-based diagnostic tools for ovarian, breast, and pancreatic cancer through the use of urine as an analytical biofluid.
Nolen BM; Lokshin AE
Int J Biol Markers; 2011; 26(3):141-52. PubMed ID: 21928247
[TBL] [Abstract][Full Text] [Related]
9. [Liquid biopsy: a possible approach for cancer screening].
Thierry AR; Tanos R
Med Sci (Paris); 2018 Oct; 34(10):824-832. PubMed ID: 30451677
[TBL] [Abstract][Full Text] [Related]
10. Molecular biomarkers for cancer detection in blood and bodily fluids.
Feng Q; Yu M; Kiviat NB
Crit Rev Clin Lab Sci; 2006; 43(5-6):497-560. PubMed ID: 17050080
[TBL] [Abstract][Full Text] [Related]
11. ADAM Metalloprotease-Released Cancer Biomarkers.
Herrlich P; Herrlich A
Trends Cancer; 2017 Jul; 3(7):482-490. PubMed ID: 28718403
[TBL] [Abstract][Full Text] [Related]
12. Bioassay of saliva proteins: The best alternative for conventional methods in non-invasive diagnosis of cancer.
Eftekhari A; Hasanzadeh M; Sharifi S; Dizaj SM; Khalilov R; Ahmadian E
Int J Biol Macromol; 2019 Mar; 124():1246-1255. PubMed ID: 30513307
[TBL] [Abstract][Full Text] [Related]
13. Cancer biomarker discovery: lectin-based strategies targeting glycoproteins.
Clark D; Mao L
Dis Markers; 2012; 33(1):1-10. PubMed ID: 22710864
[TBL] [Abstract][Full Text] [Related]
14. Utilising extracellular vesicles for early cancer diagnostics: benefits, challenges and recommendations for the future.
Pink RC; Beaman EM; Samuel P; Brooks SA; Carter DRF
Br J Cancer; 2022 Feb; 126(3):323-330. PubMed ID: 35013578
[TBL] [Abstract][Full Text] [Related]
15. A Model-Based Personalized Cancer Screening Strategy for Detecting Early-Stage Tumors Using Blood-Borne Biomarkers.
Hori SS; Lutz AM; Paulmurugan R; Gambhir SS
Cancer Res; 2017 May; 77(10):2570-2584. PubMed ID: 28283654
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicles in Cancer Detection: Hopes and Hypes.
Hu T; Wolfram J; Srivastava S
Trends Cancer; 2021 Feb; 7(2):122-133. PubMed ID: 33008796
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Exosomal Protein Detection Via Liquid Biopsy Biosensors for Cancer Screening, Diagnosis, and Prognosis.
Liu C; Yang Y; Wu Y
AAPS J; 2018 Mar; 20(2):41. PubMed ID: 29520676
[TBL] [Abstract][Full Text] [Related]
18. A highly accurate inclusive cancer screening test using Caenorhabditis elegans scent detection.
Hirotsu T; Sonoda H; Uozumi T; Shinden Y; Mimori K; Maehara Y; Ueda N; Hamakawa M
PLoS One; 2015; 10(3):e0118699. PubMed ID: 25760772
[TBL] [Abstract][Full Text] [Related]
19. Use of Biomarkers in Screening for Cancer.
Duffy MJ
Adv Exp Med Biol; 2015; 867():27-39. PubMed ID: 26530358
[TBL] [Abstract][Full Text] [Related]
20. Detection of incipient tumours by screening of circulating plasma DNA: hype or hope?
Lenaerts L; Tuveri S; Jatsenko T; Amant F; Vermeesch JR
Acta Clin Belg; 2020 Feb; 75(1):9-18. PubMed ID: 31578135
[No Abstract] [Full Text] [Related]
[Next] [New Search]
